Combination lipid-lowering therapy with statins: safety issues in the postcerivastatin era.
Jacobson, Terry A
Combination lipid-lowering therapy with statins: safety issues in the postcerivastatin era. [electronic resource] - Expert opinion on drug safety May 2003 - 269-86 p. digital
Publication Type: Comparative Study; Journal Article; Review
1474-0338
10.1517/14740338.2.3.269 doi
Cytochrome P-450 Enzyme System--metabolism
Drug Interactions
Drug Therapy, Combination
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors--adverse effects
Hyperlipidemias--drug therapy
Lipids--blood
Muscular Diseases--chemically induced
Practice Guidelines as Topic
Product Surveillance, Postmarketing
Pyridines--adverse effects
Risk Factors
Combination lipid-lowering therapy with statins: safety issues in the postcerivastatin era. [electronic resource] - Expert opinion on drug safety May 2003 - 269-86 p. digital
Publication Type: Comparative Study; Journal Article; Review
1474-0338
10.1517/14740338.2.3.269 doi
Cytochrome P-450 Enzyme System--metabolism
Drug Interactions
Drug Therapy, Combination
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors--adverse effects
Hyperlipidemias--drug therapy
Lipids--blood
Muscular Diseases--chemically induced
Practice Guidelines as Topic
Product Surveillance, Postmarketing
Pyridines--adverse effects
Risk Factors